scholarly journals OBESITY DOES NOT PREDICT LONG TERM OUTCOMES IN MINIMALLY INVASIVE MITRAL VALVE SURGERY FOR DEGENERATIVE MITRAL VALVE DISEASE

2019 ◽  
Vol 73 (9) ◽  
pp. 2022 ◽  
Author(s):  
Neal Foley ◽  
Renaldo Williams ◽  
Rushikesh Vyas ◽  
Leslie Busbee ◽  
Shi Huang ◽  
...  
2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Yi Chen ◽  
Ling-chen Huang ◽  
Dao-zhong Chen ◽  
Liang-wan Chen ◽  
Zi-he Zheng ◽  
...  

Abstract Introduction Totally endoscopic technique has been widely used in cardiac surgery, and minimally invasive totally endoscopic mitral valve surgery has been developed as an alternative to median sternotomy for many patients with mitral valve disease. In this study, we describe our experience about a modified minimally invasive totally endoscopic mitral valve surgery and reported the preliminary results of totally endoscopic mitral valve surgery. The aim of this retrospective study is to evaluate the results of totally endoscopic technique in mitral valve surgery. Material and methods We retrospectively reviewed the profiles of 188 patients who were treated for mitral valve disease by modified totally endoscopic mitral valve surgery at our institution between January 2019 and December 2020. The procedure was performed under endoscopic right minithoracotomy and with femoro-femoral cannulation using the single two-stage venous cannula. Results A total of 188 patients underwent total endoscopic mitral valve surgery. Fifty-six patients had concomitant tricuspid valvuloplasty, 11 patients underwent concomitant ablation of atrial fibrillation and atrial septal defect repair was performed in three patients. Only one patient postoperatively died of multi-organ failure. Two patients were converted to median sternotomy. Except for one patient underwent operation to stop the bleeding from the incision site, no other serious complications nor reintervention occurred during the follow-up period. Conclusions The modified totally endoscopic mitral valve surgery performed at our institution is technically feasible and safe with the same efficacy as reported studies.


2015 ◽  
Vol 10 (1) ◽  
Author(s):  
Mattia Glauber ◽  
Antonio Miceli ◽  
Daniele Canarutto ◽  
Antonio Lio ◽  
Michele Murzi ◽  
...  

2014 ◽  
Vol 19 (suppl 1) ◽  
pp. S28-S28
Author(s):  
M. Glauber ◽  
A. Miceli ◽  
D. Canarutto ◽  
M. Ferrarini ◽  
P. A. Farneti ◽  
...  

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
A B ElKerdany ◽  
M A Elghanam ◽  
M A Gamal ◽  
T M E Abdelmoneim

Abstract Introduction Full median sternotomy has been well established as a standard approach for all types of open heart surgery for many years. Although well established, the full sternotomy incision has been frequently criticized for its length, post operative pain and possible complications. Minimally invasive mitral valve surgery can be an appealing feasible alternative to the conventional full sternotomy approach with low perioperative morbidity and short-term mortality. We here made meta-analysis to compare perioperative outcomes of MIMVS versus CMVS in patients with mitral valve disease. Methods A systematic review of studies comparing perioperative outcomes of MIMVS versus CMVS in patients with mitral valve disease, from 2012 up to 2017. Review Manager 5.2 (Cochrane Collaboration) was employed to analyze the results. The outcomes of interest are mortality, cerebrovascular accidents, wound infection, reexploration due to bleeding, and LVEF assessment post-surgery. Results 12 studies involving 10279 patients were included in the meta-analysis. The 30-day mortality was significantly decreased with MIMVS; 1.6% in the MIMVS group and 2.9% in the group treated through a conventional sternotomy. Cerebrovascular events were significantly decreased with MIMVS; the stroke rate was 0.9% in MIMVS patients and 3% in patients treated via a conventional sternotomy. Wound infections, reexploration due to bleeding, and LVEF did not differ significantly between both groups. Conclusion The perioperative outcome is more or less similar for minimally invasive mitral valve surgery and conventional mitral valve surgery performed via median sternotomy. Given balance in outcomes, MIMVS is at least as safe as the standard approach and can be considered a routine and standard approach for mitral valve surgery.


Author(s):  
Vo Tuan Anh ◽  
Nguyen Thi Thu Trang ◽  
Pham Tran Viet Chuong ◽  
Vu Tam Thien ◽  
Nguyen Hoang Dinh

Hồi cứu mô tả loạt ca các bệnh nhân được phẫu thuật van hai lá ít xâm lấn qua đường mở ngực phải nhỏ có nội soi lồng ngực hỗ trợ tại bệnh viện Đại học Y Dược Thành phố Hồ Chí Minh  từ  tháng  8/2014  đến  tháng  8/2018.  Có 183 trường hợp phẫu thuật van hai lá, trong đó có 86trường hợp sửa van, tuổi trung bình 50.1 ±12.6 tuổi. Tỷ lệ nam/nữ là 1.2:1. Trong đó có 76 trường hợp van thoái hóa, 1 trường hợp van hậu thấp, 2 trường hợp viêm nội tâm mạc nhiễm trùng, 3 trường hợp tổn thương mép van và 4 trường hợp tim bẩm sinh. Cơ chế tổn thương chính là sa lá sau (59 trường hợp), đứng thứ hai là sa lá trước với 17 trường hợp, sa cả lá trước và lá  sau có 5 trường hợp và chẻ lá van chiếm 4 trường hợp phẫu thuật, 1 trường hợp có giới hạn lá van. 15 trường hợp có biến chứngtrong đó, tràn máu màng ngoài phổi cần dẫn lưu có 4 trường  hợp,  1  trường  hợp  vỡ  vòng  van,  1 trường hợp mổ lại do hở tồn lưu và 9 trường hợp mổ lại do chảy máu, 1 trường hợp hẹp động mạch đùi phải cần mổ lại. Không có tử vong. Tỉ lệ sửa van hai lá thành công (không hở hoặc hở độ 1 trên siêu âm sau mổ) cao (93%).


2018 ◽  
Vol 08 (08) ◽  
pp. 127-139
Author(s):  
Matthew Jackson ◽  
Manraj S. Sandhu ◽  
Chao Dong ◽  
Bilal Bawamia ◽  
Muhammad Qureshi ◽  
...  

2013 ◽  
Vol 61 (S 01) ◽  
Author(s):  
S Leontyev ◽  
P Davierwala ◽  
M Schneevoigt ◽  
S Lehmann ◽  
J Seeburger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document